AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Glutaryl-MV1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Vakula Health Care Private Limited

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glutaryl-MV1 Tablet SR

DiaGlyc-SR tablets are classified as antidiabetic medications, a combination therapy for adult-onset type 2 diabetes. This medication assists in regulating blood glucose. DiaGlyc-SR should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms—sweating, dizziness, headache, tremors—and appropriate countermeasures. Maintain regular mealtimes and carry a rapid-acting glucose source, like sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your physician prior to use, as it may be unsuitable. Pregnant or lactating individuals should consult their doctor before commencing treatment. Regular blood glucose monitoring is essential, and your physician may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glutaryl-MV1 Tablet SR

The provided text is "undefined," offering no content to rephrase. Therefore, no rewritten text can be provided.

Uses of Glutaryl-MV1 Tablet SR

Managing type 2 diabetes

Major Benefits of Glutaryl-MV1 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glutaryl-MV1 Tablet SR should be administered on an empty stomach.

Common Side effects of Glutaryl-MV1 Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glutaryl-MV1 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glutaryl-MV1 Tablet SR should be administered on an empty stomach.

How Glutaryl-MV1 Tablet SR works:

Sustained-release Glutaric acid-modified tablet MV1 contains a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glutaryl-MV1 Tablet SR and alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glutaryl-MV1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Glutaryl-MV1 Tablet may pose a risk to breastfeeding infants. Available human data indicates potential transfer to breast milk with consequent infant harm.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Glutaryl-MV1 Tablet SR, as its use may be unsafe. Seek medical advice before taking this medication. Furthermore, its use is contraindicated in patients with severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Glutaryl-MV1 Tablet SR cautiously, potentially requiring dose modification. Consult a physician. A low initial dose is typically prescribed for those with mild to moderate liver disease; however, it's unsuitable for patients experiencing severe hepatic dysfunction.

What if you forget to take Glutaryl-MV1 Tablet SR :

Should you forget to take a Glutaryl-MV1 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glutaryl-MV1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glutaryl-MV1 Tablet SR

Glutaryl-MV1 SR tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination therapy, used alongside diet and exercise, improves blood glucose control. Glimepiride stimulates insulin release from the pancreas, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. It's not suitable for type 1 diabetes.
Glutaryl-MV1 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste perception, gas, stomach pain, headache, skin rash, and respiratory infections.
Glutaryl-MV1 Tablet SR is contraindicated in patients allergic to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis (including diabetic ketoacidosis).
Combining Glutaryl-MV1 Tablet SR and alcohol is unsafe. This combination may worsen low blood sugar and raise the risk of lactic acidosis.
Glutaryl-MV1 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Store this medication in its original, tightly closed container as directed on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Glutaryl-MV1 Tablet SR
112
MRP 130
13% off